Arrhythmia Alliance News & Events

AliveCor

Arrhythmia Alliance Subsidized KardiaMobile Devices

Are you an Atrial Fibrillation patient worried about being in AF? 

Maybe you’re post-AF ablation and need to send an EKG? 

Has your arrhythmia EKG been cancelled, or your outpatient clinic is closed? 

AliveCor’s KardiaMobile allows you to take a medical-grade EKG in just 30 seconds, anytime, anywhere. You can share this with your physician from the convenience of your own home. 

Subsidized price $80 + P&P

To access a subsidized KardiaMobile device (one per family), email here >>> francesca@heartrhythmalliance.org

Emergency Use of KardiaMobile 6L to Help COVID-19 Patients

AliveCor’s personal EKG device, KardiaMobile 6L can now be used by medical professionals to help evaluate QTc in COVID-19 patients who are receiving QTc prolonging medication, including Hydroxychloroquine and Azithromycin. Medical professionals may use KardiaMobile 6L for patients in-hospital or at home.

 

EKG data will flow directly from AliveCor’s clinician platform to an independent testing facility staffed by CRAT or CCT certified technicians under direct physician supervision. QTc values will be measured and returned to front-line care providers within an hour. Learn more and request devices here.

Price $149 + P&P

To access a KardiaMobile device, email here >>> francesca@heartrhythmalliance.org

BardyDX CAM from Dot Medical Ltd

Direct-to-Patient ECG Ambulatory Monitoring 

 

Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing the most diagnostically-accurate and patient-friendly cardiac monitors in the industry.

The Carnation Ambulatory Monitor™ (CAM Patch) is a continuously recording P-wave centric™ ambulatory ECG patch monitor that records for up to 14 days, and is designed to provide extended duration cardiac monitoring for people who are suspected of having cardiac arrhythmias.

The CAM Patch has also been used in hospital protocols to monitor life-threatening QT Interval prolongation and related arrhythmias in COVID-19 Patients who have been prescribed Hydroxychloroquine (HCQ). The CAM Patch is clinically validated to measure QT intervals and had shown a four-times increase in arrhythmia detection in comparison to a traditional 3-lead Holter.1

The CAM Mail-to-Patient Program includes patient education materials, a telephone support hotline and an easy return-by-mail feature following completion of monitoring duration.

The CAM Patch has also been used in hospital protocols to monitor life-threatening QT Interval prolongation and related arrhythmias in COVID-19 Patients who have been prescribed Hydroxychloroquine (HCQ).

For more information, visit www.bardydx.com.

 


Get in touch for more help and information

843-415-1886info-us@heartrhythmalliance.org

Share

Send us your feedback

Patient Resources

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site